billHR7520Event Thursday, February 12, 2026Analyzed

Efficiency Adjustment Delay Act

Bullish

Summary

HR7520 delays a scheduled Medicare physician fee schedule efficiency adjustment until 2030, preserving current payment rates. This is a near-term positive for healthcare providers and Medicare Advantage insurers, preventing cuts that would have reduced revenue. The bill is early in the legislative process, so upside is not guaranteed, but the delay protects billions in Medicare payments.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR7520 delays Medicare physician payment cuts, supporting hospital and provider revenue.
  • 2.Preserves ~$2-5B in annual Medicare spending that would have been cut.
  • 3.Beneficiaries: acute care hospitals, dialysis providers, labs, Medicare Advantage insurers.
  • 4.Early-stage bill with bipartisan sponsorship; legislative path remains long.

Market Implications

The bill's delay of Medicare physician payment cuts is a positive for healthcare services stocks. HCA, UHS, DVA, DGX, LH, UNH, and HUM all have significant exposure to Medicare revenue. If the bill gains momentum, these stocks could see relative outperformance. However, the early-stage nature limits immediate catalysts. Investors should monitor committee markups and CBO score.

Full Analysis

The 'Efficiency Adjustment Delay Act' (HR7520) was introduced by Rep. Estes (R-KS) on February 12, 2026, and referred to the Energy and Commerce and Ways and Means committees. The bill delays implementation of a CMS efficiency adjustment to work Relative Value Units (RVUs) under the Medicare Physician Fee Schedule until January 1, 2030. The adjustment, originally set to phase in earlier, would have reduced payment rates for physician services. By delaying, the bill maintains current higher reimbursement levels.

This is an authorization-only bill—it does not appropriate funds, but it prevents reductions in existing spending. The Congressional Budget Office would likely score this as increasing mandatory spending (or reducing savings). The bill has 12 cosponsors and is early-stage; it requires committee action, floor votes, and Senate passage.

The money trail: Medicare Physician Fee Schedule payments are a major funding stream for hospitals, physician groups, and labs. Medicare paid ~$90B under the fee schedule in 2025. The adjustment would have reduced rates by an estimated 2-5% over several years. Delaying that preserves roughly $2-5B annually across the system. Private insurers also benefit indirectly because Medicare Advantage benchmarks are tied to fee-for-service costs.

Structural winners: Acute care hospitals (HCA, UHS) with high Medicare exposure; dialysis providers (DVA) reliant on nephrologist referrals; diagnostic labs (DGX, LH) whose professional component payments are tied to the fee schedule; and Medicare Advantage plans (UNH, HUM) that benefit from higher benchmark rates. Losers are minimal; the bill simply maintains status quo. However, some budget hawks may oppose the revenue loss.

Timeline: Next steps include markup in one or both committees, House floor vote, Senate consideration. Given bipartisan interest (cosponsor Suozzi is a Democrat), passage odds are moderate but uncertain in a divided Congress.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$HCA▲ Bullish
Est. $200.0M$400.0M revenue impact

What the bill does

Delays implementation of an efficiency adjustment to work relative value units under the Medicare physician fee schedule until 2030, maintaining current higher payment rates for physician services.

Who must act

Centers for Medicare & Medicaid Services (CMS)

What happens

Medicare physician payment rates remain at current levels instead of being reduced by the efficiency adjustment, increasing Medicare reimbursement for physician services provided by hospitals and affiliated physicians.

Stock impact

HCA Healthcare's hospital-based physician services and outpatient departments receive higher Medicare payments, boosting revenue. Medicare accounts for ~30% of HCA's revenue; a typical 5-10% cut avoided could preserve $200-400M annually.

$$UHS▲ Bullish
Est. $50.0M$100.0M revenue impact

What the bill does

Delays implementation of an efficiency adjustment to work relative value units under the Medicare physician fee schedule until 2030, maintaining current higher payment rates for physician services.

Who must act

Centers for Medicare & Medicaid Services (CMS)

What happens

Medicare physician payment rates remain at current levels instead of being reduced, increasing reimbursement for physician services provided by UHS acute care hospitals.

Stock impact

Universal Health Services' acute care hospitals benefit from stable Medicare physician payment rates. Medicare accounts for ~28% of UHS revenue; avoiding a cut preserves an estimated $50-100M annually.

Key Legislators

Rep. Estes, Ron [R-KS-4]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →